Skip to content
OpenCapital
Get started

Albertsons Companies ACI Pharmacy — Receivables, net

Similar metrics at other companies

McKesson logo
MCKNorth American Pharmaceutical — Receivables, net
$443M+41.5%
Neurocrine Biosciences logo
NBIXAccounts Receivable
$768.1M+48.9%
Vertex Pharmaceuticals logo
VRTXAccounts Receivable
$2B+10.6%
Incyte logo
INCYAccounts Receivable
$1.05B+27.7%
Service Corporation International logo
SCICurrent — Receivables, net
$102K+20.0%
Eli Lilly logo
LLYAccounts Receivable
$18.43B+53.1%

Other financials

Income statement

See full
Revenue$20.3B+7.7%
Gross profit$5.5B+7.1%
Operating income$489.7M-5.6%
Net income$293.3M-26.8%
EPS (diluted)$0.55-20.3%

Balance sheet

See full
Cash & equivalents$198.6M-33.3%
Total debt$15.7B+7.1%
Total equity$1.8B-45.8%
Total assets$26.8B0.0%

Cash flow

See full
Operating cash flow$717.1M-5.5%
CapEx$426.6M-12.0%
Free cash flow$290.5M+6.0%

Valuation

See full
Market cap$6.65B-24.5%
Enterprise value$22.16B-7.0%
P/S0.1×0.0×

Profitability

See full
Gross margin27.2%-0.5pp
Operating margin1.9%-0.7pp
Net margin1.2%-0.4pp
FCF margin-0.8%—

Returns & leverage

See full
Return on equity31.3%-28.2pp
Debt / equity8.6×+4.2×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Albertsons Companies in its filing.

Tagged under the XBRL concept us-gaap:ReceivablesNetCurrent.

The official record: Albertsons Companies’s 10-K, filed April 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Albertsons Companies's pharmacy — receivables, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Albertsons Companies's pharmacy — receivables, net?
Albertsons Companies (ACI) reported pharmacy — receivables, net of $519.8M in Q4 2025.
How has Albertsons Companies's pharmacy — receivables, net changed year-over-year?
Albertsons Companies's pharmacy — receivables, net increased by 12.0% year-over-year, from $464.1M to $519.8M.
What does pharmacy — receivables, net mean?
This metric represents the net amount of accounts receivable specifically attributable to pharmacy operations after accounting for allowances for doubtful accounts. It reflects the outstanding balance owed to the company by third-party payers, such as insurance providers and government programs, for prescription drugs and clinical services dispensed. Monitoring this balance is essential for assessing the liquidity and collection efficiency of the pharmacy business segment.